Related Experiment Video
Updated: Dec 29, 2025
High-Contrast and Fast Photorheological Switching of a Twist-Bend Nematic Liquid Crystal
Published on: October 31, 2019
Selective Sequence for the Peptide-Triggered Phase Transition of Lyotropic Liquid-Crystalline Structures
Qingtao Liu1, Yao-Da Dong1, Ben J Boyd1
1Drug Delivery, Disposition and Dynamics and ‡ARC Centre of Excellence in Convergent Bio-Nano Science and Technology, Monash Institute of Pharmaceutical Sciences, Monash University (Parkville Campus) , 381 Royal Parade, Parkville, VIC 3052, Australia.
Researchers developed selective peptide-sequence-sensing lyotropic liquid-crystalline (LLC) systems. These novel systems transform from liposomes to cubosomes upon detecting a specific peptide, showing high selectivity for targeted drug delivery applications.
Area of Science:
- Biomaterials Science
- Nanotechnology
- Drug Delivery Systems
Background:
- Lyotropic liquid-crystalline (LLC) phases are versatile for advanced material applications.
- Developing selective sensing mechanisms within these systems remains a challenge.
- Peptide-specific interactions are crucial for targeted therapeutic interventions.
Purpose of the Study:
- To investigate the use of mixed lipids for creating peptide-sequence-sensing LLC dispersion systems.
- To engineer a novel peptide-lipid (peplipid) for specific recognition of the RARAR peptide sequence.
- To explore the structural transformation of LLC systems in response to target peptide binding.
Main Methods:
- Construction of LLC systems using phytantriol and a synthesized peptide-lipid (peplipid).
- Characterization of LLC particle structures (liposomes to cubosomes) using techniques like [mention specific techniques if available, e.g., cryo-TEM, SAXS].
- Testing the selectivity of the system by exposing it to the target RARAR peptide and common human proteins.
Main Results:
- The LLC systems successfully transitioned from a lamellar structure (liposomes) to an inverse bicontinuous cubic phase (cubosomes) in the presence of the target RARAR peptide.
- No structural changes were observed when common human proteins were introduced, demonstrating high specificity for the target peptide.
- The synthesized peplipid facilitated the selective sensing and structural response.
Conclusions:
- A novel concept for selective peptide-sequence-sensing LLC dispersion systems has been successfully demonstrated.
- The developed system exhibits high specificity, transitioning structure only upon binding the target peptide.
- This technology holds significant potential for the development of targeted controlled-release drug delivery agents.
